跳至主要内容
临床试验/NL-OMON29781
NL-OMON29781招募中2 期

Influence on brain perfusion and metabolism through pharmacologic agents - perfusie_pharma

niversitair Medisch Centrum Groningen0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) a diagnosis of MS, according to the McDonald criteria with a secondary progressive disease course and a disease duration of between ten and fifteen years
  • 2) age 18-60 years
  • 3) informed consent

排除标准

  • 1) use of systemic corticosteroids in the eight weeks before inclusion into the trial
  • 2) use of immunomodulatory treatments for MS
  • 3) a history of cerebral pathology other than MS (cerebral infarct, cerebral haemorrhage, Parkinson's disease, Alzheimer's disease, cerebral vasculitis, brain absces)
  • 4) diabetes mellitus, cardiac arrhytmia, prolonged qt time on ecg, pregnancy or breast feeding.

研究者

相似试验